Daré Bioscience Enters into Exclusive Worldwide License Agreement for Juniper Pharmaceuticals’ Intravaginal Ring (IVR) Technology Platform
cannabis investing Lexaria Enters Definitive License Agreement with California Cannabis Beverage Manufacturer
cannabis investing Lexaria Achieves Significant Breakthrough in Alternative Nicotine Delivery Technology
pharmaceutical investing pSivida Announces Transformative Acquisition of Icon Bioscience and Growth Capital Financing with Essex Woodlands Healthcare Partners
medical device investing Milestone Scientific’s CompuFlo® Epidural Instrument Receives License to Sell in Canada
pharmaceutical investing CURE Pharmaceutical Announces Closing of $1 Million Bridge Financing and Prepares to Uplist to NASDAQ
cannabis investing Lexaria Bioscience Corp. Receives New U.S. Patent Allowance for “Composition of Matter” Cannabinoid Delivery
pharmaceutical investing Neos Therapeutics Reports Fourth Quarter and Full-Year 2017 Financial Results
